<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="iso-abbrev">Neuropsychiatr Dis Treat</journal-id><journal-id journal-id-type="publisher-id">Neuropsychiatric Disease and Treatment</journal-id><journal-title-group><journal-title>Neuropsychiatric Disease and Treatment</journal-title></journal-title-group><issn pub-type="ppub">1176-6328</issn><issn pub-type="epub">1178-2021</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29416340</article-id><article-id pub-id-type="pmc">5790087</article-id><article-id pub-id-type="doi">10.2147/NDT.S152208</article-id><article-id pub-id-type="publisher-id">ndt-14-383</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Self-stigma and treatment effectiveness in patients with anxiety disorders &#x02013; a mediation analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ociskova</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="af1-ndt-14-383">1</xref><xref ref-type="corresp" rid="c1-ndt-14-383"/></contrib><contrib contrib-type="author"><name><surname>Prasko</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="af1-ndt-14-383">1</xref></contrib><contrib contrib-type="author"><name><surname>Vrbova</surname><given-names>Kristyna</given-names></name><xref ref-type="aff" rid="af1-ndt-14-383">1</xref></contrib><contrib contrib-type="author"><name><surname>Kasalova</surname><given-names>Petra</given-names></name><xref ref-type="aff" rid="af1-ndt-14-383">1</xref></contrib><contrib contrib-type="author"><name><surname>Holubova</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="af1-ndt-14-383">1</xref></contrib><contrib contrib-type="author"><name><surname>Grambal</surname><given-names>Ales</given-names></name><xref ref-type="aff" rid="af1-ndt-14-383">1</xref></contrib><contrib contrib-type="author"><name><surname>Machu</surname><given-names>Klara</given-names></name><xref ref-type="aff" rid="af2-ndt-14-383">2</xref></contrib></contrib-group><aff id="af1-ndt-14-383">
<label>1</label>Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc</aff><aff id="af2-ndt-14-383">
<label>2</label>Department of Psychology, Faculty of Arts, University of Ostrava, Ostrava, The Czech Republic</aff><author-notes><corresp id="c1-ndt-14-383">Correspondence: Marie Ociskova, Department of Psychiatry, University Hospital Olomouc, IP Pavlova 6, 775 20 Olomouc, The Czech Republic, Tel +420 588 443 513, Email <email>marie.ociskova@upol.cz</email></corresp></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>26</day><month>1</month><year>2018</year></pub-date><volume>14</volume><fpage>383</fpage><lpage>392</lpage><permissions><copyright-statement>&#x000a9; 2018 Ociskova et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2018</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Goal</title><p>The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship.</p></sec><sec><title>Method</title><p>Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study. The average age was 39.2&#x000b1;12.4 years; two-thirds were women. Most of the patients used a long-term medication. The participants underwent either cognitive behavioral therapy (CBT) or short psychodynamic therapy. The selection to the psychotherapy was not randomized. All individuals completed several scales &#x02013; Beck Depression Inventory, the second edition (BDI-II), Beck Anxiety Inventory (BAI), Dissociative Experience Scale (DES), Sheehan Disability Scale (SDS), subjective Clinical Global Impression (subjCGI), and The Internalized Stigma of Mental Illness Scale (ISMI). A senior psychiatrist filled out the objective CGI (objCGI).</p></sec><sec><title>Results</title><p>The patients significantly improved in the severity of anxiety (BAI), depression (BDI-II), and overall severity of the mental disorder (objCGI). The self-stigma predicted a lower change of the objCGI, but not a change of the anxiety and depressive symptoms severity. Anxiety, depressive symptoms, dissociation, and disability were assessed as possible mediators of the relationship between the self-stigma and the treatment change. None of them were significant.</p></sec><sec><title>Conclusion</title><p>Self-stigma lowers the effectiveness of the combined treatment of anxiety disorders. Future research should explore other possible mediators influencing this relationship.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>self-stigma</kwd><kwd>anxiety disorders</kwd><kwd>treatment effectiveness</kwd><kwd>medication</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>During the last two decades, researchers have increasingly focused on a specific type of patients&#x02019; understanding of their mental issues &#x02013; one which stems from the mental illness stereotypes and prejudices.<xref rid="b1-ndt-14-383" ref-type="bibr">1</xref> It has been found that some patients, who are aware of the prejudices, agree with them, and subsequently apply them in their case. This type of interpretation of one&#x02019;s mental struggles is known as self-stigma.<xref rid="b1-ndt-14-383" ref-type="bibr">1</xref></p><p>Through negative lenses of stigma, an individual attributes his mental struggles to internal, unchangeable, and global causes (which makes self-stigma related to the depressive attributional style described by Seligman et al<xref rid="b2-ndt-14-383" ref-type="bibr">2</xref>). In accordance with wide-spread prejudices, the patient may think that he is somehow inferior, weak, unwanted, or unreliable because of his mental issues.<xref rid="b3-ndt-14-383" ref-type="bibr">3</xref> As these interpretations tend to be rigidly held, and as they are unrealistically negative and unbalanced (&#x0201c;I am weak, inferior, different, &#x02026;&#x0201d;), the self-stigma induces stress.<xref rid="b4-ndt-14-383" ref-type="bibr">4</xref></p><p>When the individual stigmatizes himself, his self-esteem declines.<xref rid="b5-ndt-14-383" ref-type="bibr">5</xref>,<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref> Thinking that one is weak or inferior, the patient loses trust in oneself. A loss of a sense of mastery and hopelessness follow.<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref>&#x02013;<xref rid="b8-ndt-14-383" ref-type="bibr">8</xref> As a result of the changes in self-concept, symptoms of anxiety and depression occur or are exacerbated.<xref rid="b5-ndt-14-383" ref-type="bibr">5</xref>,<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref></p><p>Self-stigma has also been related to dissociation. Patients with high rates of self-stigma express high dissociation levels.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref>,<xref rid="b10-ndt-14-383" ref-type="bibr">10</xref> Both factors are associated with worse treatment outcomes.<xref rid="b7-ndt-14-383" ref-type="bibr">7</xref>,<xref rid="b11-ndt-14-383" ref-type="bibr">11</xref> It is possible that they are the result of aversive childhood experiences.<xref rid="b12-ndt-14-383" ref-type="bibr">12</xref> Self-stigma is related to negative core beliefs that are predominantly formed in childhood and relate to early aversive experiences.<xref rid="b12-ndt-14-383" ref-type="bibr">12</xref> Excessive use of dissociation also develops in childhood, when the child is exposed to traumatic experiences that they cannot handle other than by the splitting of integrative mental functions, such as memory, emotions, cognition, and physical perceptions.<xref rid="b10-ndt-14-383" ref-type="bibr">10</xref></p><p>Some changes, which result from self-stigmatization, may also be noticed in the patients&#x02019; social behavior.<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref> A person who stigmatizes himself is often afraid that others could do the same to him. Because of this fear, the individual may try to conceal their mental issues or isolate themselves from society and loved ones.<xref rid="b13-ndt-14-383" ref-type="bibr">13</xref> Self-stigma worsens social functioning.<xref rid="b8-ndt-14-383" ref-type="bibr">8</xref></p><p>The changes in self-concept and related demoralization are also reflected in the treatment.<xref rid="b14-ndt-14-383" ref-type="bibr">14</xref>,<xref rid="b20-ndt-14-383" ref-type="bibr">20</xref> Stigma has been connected with worse adherence in the pharmacotherapy of mental disorders,<xref rid="b15-ndt-14-383" ref-type="bibr">15</xref>,<xref rid="b16-ndt-14-383" ref-type="bibr">16</xref> and with worse attendance on psychosocial rehabilitation programs.<xref rid="b17-ndt-14-383" ref-type="bibr">17</xref> The self-stigmatizing patients tend to discontinue medication of their own will, or do not follow the necessary treatment regime.<xref rid="b15-ndt-14-383" ref-type="bibr">15</xref> As for the anxiety disorders, self-stigma leads to lower effectiveness of the pharmacotherapy<xref rid="b16-ndt-14-383" ref-type="bibr">16</xref> and the combined treatment of psychotherapy and pharmacotherapy.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref> Despite the intensive treatment, patients with self-stigmatizing tendencies often remain significantly anxious and improve less than those who do not stigmatize themselves.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref>,<xref rid="b11-ndt-14-383" ref-type="bibr">11</xref></p><p>Anxiety disorders are among the most prevalent mental conditions,<xref rid="b18-ndt-14-383" ref-type="bibr">18</xref> with a considerable degree of disability.<xref rid="b19-ndt-14-383" ref-type="bibr">19</xref> At the same time, only ~60% of anxiety disorder patients react significantly to the standardized treatments.<xref rid="b20-ndt-14-383" ref-type="bibr">20</xref> Ranging from generalized anxiety disorder<xref rid="b21-ndt-14-383" ref-type="bibr">21</xref> and social phobia<xref rid="b22-ndt-14-383" ref-type="bibr">22</xref> to panic disorder and agoraphobia,<xref rid="b23-ndt-14-383" ref-type="bibr">23</xref> all anxiety disorders show a similar pattern of commonly insufficient treatment results.<xref rid="b24-ndt-14-383" ref-type="bibr">24</xref></p><p>Several maintenance factors for anxiety disorders have been found. Some present psychosocial variables which prevent the patients from reaching remission. Rigidly held cognitive errors, maladaptive schemas, and avoidant behavior,<xref rid="b25-ndt-14-383" ref-type="bibr">25</xref> early life experiences,<xref rid="b26-ndt-14-383" ref-type="bibr">26</xref> dissociations,<xref rid="b10-ndt-14-383" ref-type="bibr">10</xref> and self-stigma<xref rid="b16-ndt-14-383" ref-type="bibr">16</xref> negatively influence the treatment response. Biological factors, such as genetics<xref rid="b27-ndt-14-383" ref-type="bibr">27</xref> and temperament,<xref rid="b26-ndt-14-383" ref-type="bibr">26</xref> also play a role. While some factors may be addressed during the treatment more readily than others (eg, cognitive errors versus maladaptive schemas), the current state of treatment effectiveness leaves much to be desired. It is vital to explore the impact of the maintenance factors on the treatment outcomes and how they work. Better exploration of this field may lead to improvements in the standardized treatments to make them more efficacious.</p><p>Self-stigma has only recently been shown to influence the treatment results in patients with anxiety disorders.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref>,<xref rid="b16-ndt-14-383" ref-type="bibr">16</xref> Although considerable attention has been paid to self-stigma in people with psychosis,<xref rid="b8-ndt-14-383" ref-type="bibr">8</xref>,<xref rid="b17-ndt-14-383" ref-type="bibr">17</xref>,<xref rid="b28-ndt-14-383" ref-type="bibr">28</xref> it is also a significant issue for many individuals with anxiety disorders.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref>,<xref rid="b29-ndt-14-383" ref-type="bibr">29</xref> Still, it is not known in which ways self-stigma maintains the psychopathology.</p><p>According to several authors,<xref rid="b5-ndt-14-383" ref-type="bibr">5</xref>,<xref rid="b30-ndt-14-383" ref-type="bibr">30</xref> self-stigma increases anxiety. Thus, it may worsen the treatment outcomes through the maintenance of anxiety. Link et al<xref rid="b31-ndt-14-383" ref-type="bibr">31</xref> also found that self-stigma predicted the severity of depressive symptoms. Hopelessness, helplessness, and related depressive symptoms have been connected to self-stigma<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref> and, as such, can lead to unfavorable treatment results too. Anxiety and depression are also associated with dissociation.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref> By splitting the consciousness, the process of therapy is blunted. Moreover, since self-stigma negatively influences functioning in life,<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref> it is possible that this disability may function as another mediator of the relationship between internalized stigma and treatment effectiveness.</p><p>Since this topic has not yet been sufficiently explored, and since self-stigma seems to play a significant role in the treatment of anxiety disorders, there were two goals in this study. The first goal was to confirm or disconfirm that self-stigma leads to worse outcomes for combined pharmacological and psychotherapeutic treatment of anxiety disorders. The second goal was to find if anxiety, depressive symptoms, dissociation, or disability are mediators of this relationship.</p><p>The hypotheses were as follows:
<list list-type="order"><list-item><p>The higher initial level of self-stigma (The Internalized Stigma of Mental Illness Scale [ISMI]) predicts the lower relative change of anxiety symptoms during the treatment (Beck Anxiety Inventory [BAI]).</p></list-item><list-item><p>The higher initial level of self-stigma (ISMI) predicts the lower relative change of depressive symptoms during the treatment (Beck Depression Inventory, the second edition [BDI-II]).</p></list-item><list-item><p>The higher initial level of self-stigma (ISMI) predicts the lower relative change of the overall mental state during the treatment, assessed by a clinician (objective Clinical Global Impression [objCGI]).</p></list-item></list></p><p>A main indicator of the treatment effect was the relative change of the overall psychopathology. The reasons for this choice were the general character of the evaluation (the assessment of the whole mental state instead of symptom clusters, such as anxiety or depressivity) and its objective nature (BAI, BDI-II, and Dissociative Experience Scale [DES] are self-evaluative; see the Methods section). As such, the relative change of the psychopathology assessed by a psychiatrist entered a fourth hypothesis dealing with the mediation:
<list list-type="simple"><list-item><label>(4)</label><p>The relationship between the higher initial self-stigma (ISMI) and lower relative change of the overall mental state (objCGI) is mediated by:
<list list-type="alpha-lower"><list-item><p>The anxiety symptoms measured at the beginning of the treatment (BAI).</p></list-item><list-item><p>The depressive symptoms measured at the beginning of the treatment (BDI-II).</p></list-item><list-item><p>The level of dissociation measured at the beginning of the treatment (DES).</p></list-item><list-item><p>Functioning in social life, assessed at the beginning of the treatment (Sheehan Disability Scale [SDS]).</p></list-item><list-item><p>Functioning in family life, assessed at the beginning of the treatment (SDS).</p></list-item><list-item><p>Functioning in occupation, assessed at the beginning of the treatment (SDS).</p></list-item></list></p></list-item></list></p></sec><sec><title>Sample and method</title><sec><title>Sample</title><p>Patients who had been hospitalized in a psychotherapeutic department between November 2012 and June 2016 were asked to participate in the study. Two hundred and nine individuals with anxiety disorders agreed, signed an informed consent form, and filled in several scales. The inclusion criteria were:
<list list-type="order"><list-item><p>Aged 18&#x02013;70 years.</p></list-item><list-item><p>A diagnosis of an anxiety disorder according to ICD-10<xref rid="b32-ndt-14-383" ref-type="bibr">32</xref> &#x02013; a social phobia, a panic disorder with/without agoraphobia, a generalized anxiety disorder, or a mixed anxiety-depressive disorder.</p></list-item></list></p><p>The exclusion criteria were:
<list list-type="order"><list-item><p>A diagnosis of an organic mental illness, intellectual disability, a psychosis, or an antisocial personality disorder.</p></list-item><list-item><p>Severe suicidal tendencies.</p></list-item></list></p><p>Psychiatric diagnostics was realized by an outpatient psychiatrist, a psychiatrist of the department, and a senior psychiatrist.</p></sec><sec><title>Measurements</title><p>The inpatients who decided to contribute to the investigation signed an informed consent form and completed several questionnaires. All were assessed by two psychiatrists for diagnostic evaluation and by a psychologist to confirm the diagnosis with a standard diagnostic interview Mini International Neuropsychiatric Interview (MINI).<xref rid="b33-ndt-14-383" ref-type="bibr">33</xref> These assessment tools were completed at the start and the end of hospitalization:
<list list-type="bullet"><list-item><p>MINI<xref rid="b33-ndt-14-383" ref-type="bibr">33</xref> is a standard diagnostic interview covering diagnostic criteria for common psychiatric disorders according to DSM-IV and ICD-10. Sensitivity is higher than 0.70 for all reviewed disorders except for dysthymia, obsessive compulsive disorder, and current drug dependence. Specificity is higher than 0.85 for all diagnoses.<xref rid="b33-ndt-14-383" ref-type="bibr">33</xref></p></list-item><list-item><p>CGI<xref rid="b34-ndt-14-383" ref-type="bibr">34</xref> is used for the global evaluation of the severity of the disorder. In this study, the objective (evaluated by a psychiatrist) and subjective (assessed by the patient) evaluation of CGI severity were used. The level of agreement between raters reaches an intra-class correlation coefficient of 0.90.<xref rid="b35-ndt-14-383" ref-type="bibr">35</xref></p></list-item><list-item><p>BAI<xref rid="b36-ndt-14-383" ref-type="bibr">36</xref> contains 21 items &#x02013; anxiety symptoms &#x02013; on a four-point Likert scale. The participant indicates symptoms and their severity during the last week. The scale has excellent internal consistency (mean &#x003b1;=0.91).<xref rid="b37-ndt-14-383" ref-type="bibr">37</xref> The validation of the Czech translation was done with excellent Cronbach alfa =0.92.<xref rid="b38-ndt-14-383" ref-type="bibr">38</xref></p></list-item><list-item><p>BDI-II<xref rid="b39-ndt-14-383" ref-type="bibr">39</xref> includes 21 items from which patients choose depressive symptoms and rate their severity. Patients assess their state during the previous week. Internal consistency of the scale is higher in the psychiatric population (&#x003b1;=0.86) than in the general population (&#x003b1;=0.81).<xref rid="b40-ndt-14-383" ref-type="bibr">40</xref> Czech standardization was performed by Ociskova et al<xref rid="b41-ndt-14-383" ref-type="bibr">41</xref> with Cronbach&#x02019;s alfa =0.90.</p></list-item><list-item><p>ISMI<xref rid="b42-ndt-14-383" ref-type="bibr">42</xref> assesses the level of self-stigma in adults with diagnosed psychiatric disorders. It consists of 29 items distributed into five subscales &#x02013; alienation, stereotype endorsement, discrimination experience, social withdrawal, and stigma resistance. Patients mark one number from a four-point Likert scale according to the level of consent with each statement.<xref rid="b42-ndt-14-383" ref-type="bibr">42</xref> Cronbach&#x02019;s alpha of the method is excellent (&#x003b1;=0.90). The Czech version of the scale has an equivalent internal consistency (&#x003b1;=0.91).<xref rid="b43-ndt-14-383" ref-type="bibr">43</xref></p></list-item></list></p><p>The following methods were completed only at the start of the treatment:
<list list-type="bullet"><list-item><p>DES<xref rid="b44-ndt-14-383" ref-type="bibr">44</xref> defines 28 dissociative experiences. The patient marks a spot on a 10 cm line according to the frequency of feeling the symptoms. The pathological type of dissociation can be identified by a subgroup of eight items of the DES, the DES-Taxon (DES-T).<xref rid="b44-ndt-14-383" ref-type="bibr">44</xref> This subscale involves eight out of the 28 DES items (items 3, 5, 7, 8, 12, 13, 22, and 27).<xref rid="b45-ndt-14-383" ref-type="bibr">45</xref> The original Cronbach&#x02019;s alpha is 0.93.<xref rid="b44-ndt-14-383" ref-type="bibr">44</xref> The Czech version of the scale has similar validity, test-retest reliability, and factor structure to the original one.<xref rid="b46-ndt-14-383" ref-type="bibr">46</xref></p></list-item><list-item><p>SDS<xref rid="b47-ndt-14-383" ref-type="bibr">47</xref>,<xref rid="b48-ndt-14-383" ref-type="bibr">48</xref> is a patient-assessed, analog measure of functional disability in work, social, and family life. A patient rates the extent to which these areas of life are impaired on a 10 point scale.<xref rid="b49-ndt-14-383" ref-type="bibr">49</xref> Arbuckle et al<xref rid="b50-ndt-14-383" ref-type="bibr">50</xref> stated a Cronbach&#x02019;s alpha of 0.89.</p></list-item><list-item><p>The demographic questionnaire checked the basic information about the patients, such as gender, age, age of disease onset, education, employment status, pension status, duration of attendance in the outpatient clinic, number of hospitalizations, time since the last hospitalization, current medication, number of visited psychiatrists, and discontinuation of drugs in the past (recommended by a psychiatrist or arbitrarily).</p></list-item></list></p><p>The study primary outcome criteria were defined as:
<list list-type="bullet"><list-item><p>Relative change during the therapy in objCGI and BAI (the difference between rating at the beginning and rating at the end of the therapy divided by the beginning score).</p></list-item></list></p></sec><sec sec-type="methods"><title>Methods of treatment</title><sec><title>Psychopharmacotherapy</title><p>Patients were treated with standard doses of psychopharmacs. Medication was changed minimally. There was no significant difference between the antidepressant dosage at the beginning and at the end of the hospitalization (the starting dosage in 180 patients was 42.7&#x000b1;27.0 mg of paroxetine equivalent; the dosage at the end in 187 patients was 40.4&#x000b1;24.3 mg; paired <italic>t</italic>-test: <italic>t</italic>=1.416, <italic>df</italic>=177; not significant [ns]). Similarly, the mean dosage of the anxiolytics did not change (the starting dosage in 70 patients was 5.2&#x000b1;6.2 mg of diazepam equivalent; the ending dosage in 37 patients was 6.9&#x000b1;7.7 mg; paired <italic>t</italic>-test: <italic>t</italic>=0.712; <italic>df</italic>=32; ns). Also, the mean dosage of antipsychotics did not significantly change during the treatment (the starting dosage in 45 patients was 1.1&#x000b1;1.1 mg of risperidone equivalent; the ending dosage in 59 patients was 1.4&#x000b1;2.1 mg; paired <italic>t</italic>-test: <italic>t</italic>=&#x02212;0.679; <italic>df</italic>=39; ns). Mood stabilizers were used in eight patients at the beginning and 12 patients at the end of the hospitalization.</p></sec><sec><title>Psychotherapy</title><p>The psychotherapy was provided in two different forms: cognitive behavioral therapy (CBT) or brief psychodynamic therapy, both in a 6-week treatment program. The patients were not randomized to the type of psychotherapy. Patients were present for 30 group sessions (CBT or short psychodynamic therapy) and five individual sessions. The CBT program included therapeutic activities such as psychoeducation, case conceptualization, work with automatic thoughts and schemas, exposures, and problem-solving.<xref rid="b10-ndt-14-383" ref-type="bibr">10</xref> Short psychodynamic therapy concentrated on relational problems in a patient&#x02019;s life and group interactions, which were both related to a person&#x02019;s development. The program for both groups was supplemented with assertive training, mental imagery, relaxation, sport, and ergotherapy.</p></sec></sec><sec><title>Statistics</title><p>Statistics were calculated by using statistical software PRISM (GraphPad PRISM version 5.0), SPSS 24.0, and AMOS. The applied statistical methods were descriptive statistics for the demographic data, mean scores, and normality tests. Differences between scores were calculated by parametric or non-parametric paired or unpaired <italic>t</italic>-tests or Kruskal&#x02013;Wallis tests. Correlations were used to analyze the relationships between the treatment outcome and other factors. Effect sizes were interpreted by Cohen.<xref rid="b51-ndt-14-383" ref-type="bibr">51</xref> A mediation analysis was performed by using the maximum likelihood method with standardized estimates. Differences were considered to be significant when <italic>P</italic>-values were less than 0.05.</p></sec><sec><title>Ethics</title><p>The research was performed in agreement with the latest version of the Helsinki Declaration and the Guideline for Good Clinical Practice.<xref rid="b52-ndt-14-383" ref-type="bibr">52</xref> The ethical committee of the University Hospital in Olomouc, the Czech Republic, approved the study. Written informed consent was received from all participants after the procedures had been fully explained.</p></sec></sec><sec sec-type="results"><title>Results</title><sec sec-type="intro"><title>Descriptive and clinical characteristics of the sample</title><p>Questionnaires were completed by 209 patients (72.1%) from 290 hospitalized at the time of completing the study, and who met the entry criteria. The data of the 209 patients were statistically analyzed. Data of 81 (27.9%) patients were not used, as 22 patients prematurely dropped out from the treatment due to various reasons, the diagnosis was changed in 48 participants, and 11 individuals did not fulfill questionnaires at the end of the study.</p><p>The patients&#x02019; average age was 39.2&#x000b1;12.4 years, and the duration of the disorder was 9.7&#x000b1;9.7 years (<xref ref-type="table" rid="t1-ndt-14-383">Table 1</xref>). There were slightly more women (66%) than men. The education received was relatively regularly distributed: 10.5% of the patients had basic education, 29.2% underwent vocational training, 44.5% had secondary education, and 15.8% reached university level. When we looked at the employment status, the results showed that 38.3% of the patients were unemployed and 13.9% of the patients had a disability pension. As for marital status, 42.1% of the patients were single, another 36.4% were married, and 18.7% divorced. More than half of the patients (58.4%) had a partner (<xref ref-type="table" rid="t1-ndt-14-383">Table 1</xref>).</p><p>In all 209 patients, the primary diagnosis was anxiety disorder (30.6% individuals had panic disorder, 6.2% agoraphobia, 20.6% social phobia, 26.3% generalized anxiety disorder, and 11.7% mixed anxiety-depressive disorder).</p><p>Regarding the severity of the disorder, the average severity of the disorders ranged from &#x0201c;moderately ill&#x0201d; to &#x0201c;markedly ill&#x0201d; according to the objCGI and subjective CGI (subjCGI) severity. The mean severity of the anxiety and depressive symptoms (BAI and BDI-II, respectively) was also moderate.<xref rid="b36-ndt-14-383" ref-type="bibr">36</xref>,<xref rid="b39-ndt-14-383" ref-type="bibr">39</xref></p><p>The total scores of the self-stigma, measured by ISMI at the start and the end of the treatment, reached average levels.<xref rid="b43-ndt-14-383" ref-type="bibr">43</xref> The level of psychological dissociation, measured by DES, pointed to a slightly higher level of dissociation.<xref rid="b44-ndt-14-383" ref-type="bibr">44</xref> The values of SDS indicated moderate disabilities in work, social life, and family life on average.<xref rid="b47-ndt-14-383" ref-type="bibr">47</xref></p></sec><sec><title>Changes during the therapy</title><p>Significant improvements were observed in all parameters &#x02013; objCGI, subjCGI, BDI-II, and BAI (<xref ref-type="table" rid="t1-ndt-14-383">Table 1</xref>). The minimal improvement according to objCGI (a change of at least one point between the pre&#x02013;post measurements) was shown by 182 patients (87.2%), and a bigger improvement (the objCGI change of two points or more) was noticed in 124 individuals (59.3%). A remission, defined as the last objCGI score of 1 or 2, was achieved by 95 patients (45.5%). The treatment response with regards to the depressive symptomatology, defined as an improvement of 30% of the initial BDI-II score, was shown by 79 patients (37.8%). Similarly, the treatment response in the anxiety symptomatology, defined as an improvement of 30% of the BAI score, was found in 64 patients (30.6%).</p><p>Additionally, 101 patients completed ISMI both at the start and at the end of the hospitalization (<xref ref-type="table" rid="t1-ndt-14-383">Table 1</xref>). Although the average level of the stigma significantly decreased during the treatment, the effect size was small (Cohen&#x02019;s <italic>d</italic>=0.38).</p></sec><sec sec-type="intro"><title>Correlations of the demographic, clinical, and psychological characteristics and therapeutic change</title><p>The relative change in objCGI positively correlated with the initial levels of depression (BDI-II), anxiety (BAI), dissociation (DES), and self-stigma (ISMI) (<xref ref-type="table" rid="t2-ndt-14-383">Table 2</xref>). This indicates the patients, who had less severe symptomatology (such as anxiety, depression, dissociation, and self-stigma) at the start of the treatment, improved more during the hospitalization.</p><p>The relative change of anxiety symptomatology (BAI) negatively correlated with BAI at the beginning of the treatment. On average, the more the patient was anxious at the start of the treatment, the more they improved during its course. Lastly, the relative change in depressivity (BDI-II) was significantly positively connected with the initial level of dissociation (<xref ref-type="table" rid="t2-ndt-14-383">Table 2</xref>).</p><p>Men who attended the study improved in the severity of the depressive symptoms significantly more than women. The genders did not differ in the extent of change of the global symptomatology (objCGI) of anxiety (BAI) (<xref ref-type="table" rid="t3-ndt-14-383">Table 3</xref>).</p><p>Patients who were employed or self-employed showed a bigger improvement in global severity of the disorder than individuals without a job, but this difference was not observed in the changes in anxiety and depression levels. Also, patients with a partner improved significantly more than patients without a partner concerning the general severity of the disorder (<xref ref-type="table" rid="t3-ndt-14-383">Table 3</xref>).</p></sec><sec sec-type="methods"><title>Mediation analysis</title><p>Previous analyses indicated that the relative change of the objective (relobj) CGI might be significantly influenced by the initial level of self-stigma (ISMI), anxiety (BAI), depression (BDI-II), and dissociation (DES). Contrary to the expectations, the levels of disability (SDS) were not related to the main indicator of treatment change. Based on the theoretical background described in the Introduction, we proposed a mediation model explaining the ways through which self-stigma lowers treatment effectiveness.</p><p>The model consisted of self-stigma as a predictor; anxiety, depression, and dissociation as possible mediators, and the relative change of the psychopathology as an outcome criterion. The AMOS software was used for the calculations. The maximum likelihood method was used, as it is a gold standard in structural equation modeling and as it is robust against normality violations.<xref rid="b53-ndt-14-383" ref-type="bibr">53</xref></p><p><xref ref-type="fig" rid="f1-ndt-14-383">Figure 1</xref> contains standardized estimates of the pathways. The three paths connecting ISMI with BAI, BDI-II, and DES were significant (in all cases <italic>P</italic>&#x0003c;0.001). However, none of the mediators were significantly related to the relobjCGI. Fit indices also revealed a bad model fit (<italic>&#x003c7;</italic><sup>2</sup>=51.589; <italic>df</italic>=4; significance: 0.001; Confirmatory Fit Index (CFI) =0.675; RMSEA =0.244). As such, the anxiety, depression, and dissociation levels do not seem to explain the relationship between the self-stigma and the lower treatment effectiveness.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The aim of this study was to confirm or disconfirm a main finding of the previous study,<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref> in which the self-stigma significantly influenced the treatment effect among patients with anxiety disorders, and to identify ways in which self-stigma does so.</p><p>The demographic structure of the sample was similar to other studies in gender, age, the age of onset, heredity, occupational status, and marital status.<xref rid="b24-ndt-14-383" ref-type="bibr">24</xref>,<xref rid="b54-ndt-14-383" ref-type="bibr">54</xref>,<xref rid="b55-ndt-14-383" ref-type="bibr">55</xref> The rate of comorbidity was also similar to other studies.<xref rid="b55-ndt-14-383" ref-type="bibr">55</xref></p><p>During the 6-week treatment consisting of psychotherapy (CBT or short psychodynamic therapy) and pharmacotherapy (in most patients), the participants significantly improved in the general severity of the disorder and the anxiety and depressive levels. Approximately half of the patients (45.5%) reached a remission at the end of the treatment. Only 12.8% of the completers were non-responders. This is noticeably lower than a third of the completers &#x02013; the average percent of non-responders from a meta-analysis of studies using CBT or selective serotonin reuptake inhibitors.<xref rid="b56-ndt-14-383" ref-type="bibr">56</xref> Interestingly, the patients improved the least in their anxiety levels. This may be attributed to anticipatory anxiety at the end of the treatment. The patients were about to head home to face issues that they had been working on resolving during the hospitalization. These worries and anxieties were often verbalized by the patients. Although most participants mastered problem-solving, communication skills, and exposures, their return to their families and work often presented an exposure on its own. As such, the end of the treatment triggered anxiety in some patients.<xref rid="b24-ndt-14-383" ref-type="bibr">24</xref></p><p>The mean level of the self-stigma slightly decreased during the treatment. However, the change was barely significant. This may indicate that the standardized psychotherapeutic treatment for anxiety disorders is not sufficient to tackle this topic. The patients from both therapeutic groups were acquiring cognitive skills to deal with anxiety and related issues, but self-stigma was not explicitly addressed. A more direct approach, such as Narrative Enhancement and Cognitive Therapy,<xref rid="b57-ndt-14-383" ref-type="bibr">57</xref> could be more beneficial and perhaps could improve the treatment outcomes.</p><p>Based on the background described in the Introduction, we formulated several hypotheses. Three hypotheses explored the relationship between self-stigma and treatment effectiveness in anxiety disorders. The fourth hypothesis dealt with possible ways in which self-stigma worsens treatment outcomes.</p><p>In the first hypothesis, we expected that higher levels of self-stigma would lead to less improvement in anxiety symptoms, as self-stigma tends to increase anxiety.<xref rid="b5-ndt-14-383" ref-type="bibr">5</xref>,<xref rid="b30-ndt-14-383" ref-type="bibr">30</xref> Our previous study also found that self-stigma predicted a lower change of anxiety symptoms in patients with anxiety disorders.<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref> In the present study, self-stigma failed to predict the change of anxiety during treatment. There are several explanations for this result. The correlation coefficient of this relationship in the study of Ociskova et al<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref> was small, <italic>r</italic>=0.26. The fact, that the coefficient was so small lowers the probability of the replication of the result.<xref rid="b58-ndt-14-383" ref-type="bibr">58</xref> Another possibility is that the change in anxiety symptoms was too little to have sufficient power to discriminate potential predictors.</p><p>The second hypothesis stated that the initial level of self-stigma predicts a lower change of depressive symptoms. According to Link et al,<xref rid="b31-ndt-14-383" ref-type="bibr">31</xref> self-stigma predicts the severity of depressive symptoms and could lead to symptoms of helplessness and hopelessness. This would suggest that self-stigmatizing patients would maintain symptoms of depression and would not change much during the treatment. We did not find that this was the case. On one side, self-stigma may predict depression severity (as seen here in the mediation analysis), which is in accordance with previous studies.<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref>,<xref rid="b8-ndt-14-383" ref-type="bibr">8</xref> However, self-stigma did not predict the change in depressive symptoms severity. Future research should explore this issue in a sample of depressed individuals, and focus on the specific symptoms of depression which are influenced by self-stigma.</p><p>The third hypothesis proposed that a higher initial level of self-stigma predicted a lower change of general severity of the mental disorder during treatment. In the study of Ociskova et al,<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref> the self-stigma significantly influenced the relative change of the objCGI, with a correlation coefficient <italic>r</italic>=0.38. The present study confirmed the finding. The self-stigma seems to hinder the therapeutic efforts during standardized treatment of anxiety disorders. Since self-stigma was not related to the relative change in anxiety and depressive symptoms, its impact on the therapeutic outcomes goes beyond its influence on the emotional symptoms. It may work through avoidant behavior or adherence issues.<xref rid="b15-ndt-14-383" ref-type="bibr">15</xref>,<xref rid="b59-ndt-14-383" ref-type="bibr">59</xref> This hypothesis should be put under scrutiny in future studies.</p><p>The fourth hypothesis proposed several mediators between self-stigma and therapeutic change. We suggested that self-stigma may lower the treatment effectiveness through its maintenance of anxiety, depressive symptoms, dissociation, and disability. Even though the rationale behind this thought was based on theory and the findings of other authors,<xref rid="b6-ndt-14-383" ref-type="bibr">6</xref>,<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref>,<xref rid="b30-ndt-14-383" ref-type="bibr">30</xref>,<xref rid="b31-ndt-14-383" ref-type="bibr">31</xref> the results did not support the hypothesis. The correlation coefficients between the relative objCGI and the initial anxiety, depressive, and dissociation levels were negligible, and the mediation model did not prove their role in the process. Based on previous research,<xref rid="b9-ndt-14-383" ref-type="bibr">9</xref>,<xref rid="b10-ndt-14-383" ref-type="bibr">10</xref> we found that the relative change of the objCGI was influenced by a number of quite small predictors (ranging from clinical, such as initial disorder severity, to psychological, like dissociation) which together mildly predicted the therapeutic outcome. This study concluded with same results as well. Stronger predictors have to be found to identify mediators of the relationship between self-stigma and treatment outcomes.</p><p>To sum up, self-stigma influences the outcome of the combined therapy of anxiety disorders. Future research should find the pathways in which self-stigma decreases the therapeutic effectiveness, to help with identifying effective ways of tackling both self-stigma and anxiety disorders.</p><sec><title>Limitations</title><p>The investigation had several shortcomings. The data mainly came from self-evaluative methods. The use of such methods is conditioned on the capability of introspection of the patients and their readiness to be open in their reports. Another limitation is the broad spectrum of anxiety disorders which the patients had. A quarter of the participants had comorbidity with other anxiety disorders, and one in six suffered from a personality disorder. The patients were also treated with various medications and two different types of psychotherapy.</p></sec></sec><sec><title>Conclusion</title><p>The outcomes of the treatment of anxiety disorders have repeatedly been shown to be suboptimal. It is important to address factors that diminish the therapeutic effects. Self-stigma is one of such factors. The mechanisms in which it does so have not been identified in this study. Future research should continue with the effort to find the pathways of self-stigma impact on therapy for improvement of the treatment outcomes.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ndt-14-383"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname><given-names>PW</given-names></name><name><surname>Rao</surname><given-names>D</given-names></name></person-group><article-title>On the self-stigma of mental illness: Stages, disclosure, and strategies for change</article-title><source>Can J Psychiatry</source><year>2012</year><volume>57</volume><issue>8</issue><fpage>464</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">22854028</pub-id></element-citation></ref><ref id="b2-ndt-14-383"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seligman</surname><given-names>ME</given-names></name><name><surname>Abramson</surname><given-names>LY</given-names></name><name><surname>Semmel</surname><given-names>A</given-names></name><name><surname>von Baeyer</surname><given-names>C</given-names></name></person-group><article-title>Depressive attributional style</article-title><source>J Abnorm Psychol</source><year>1979</year><volume>88</volume><issue>3</issue><fpage>242</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">500951</pub-id></element-citation></ref><ref id="b3-ndt-14-383"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parcesepe</surname><given-names>AM</given-names></name><name><surname>Cabassa</surname><given-names>LJ</given-names></name></person-group><article-title>Public stigma of mental illness in the United States: a systematic literature review</article-title><source>Admin Policy Ment Health</source><year>2013</year><volume>40</volume><issue>5</issue><fpage>384</fpage><lpage>399</lpage></element-citation></ref><ref id="b4-ndt-14-383"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000fc;sch</surname><given-names>N</given-names></name><name><surname>Corrigan</surname><given-names>PW</given-names></name><name><surname>Powell</surname><given-names>K</given-names></name><etal/></person-group><article-title>A stress-coping model of mental illness stigma: II. Emotional stress responses, coping behavior and outcome</article-title><source>Schizophr Res</source><year>2009</year><volume>110</volume><issue>1&#x02013;3</issue><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">19237266</pub-id></element-citation></ref><ref id="b5-ndt-14-383"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drapalski</surname><given-names>AM</given-names></name><name><surname>Lucksted</surname><given-names>A</given-names></name><name><surname>Perrin</surname><given-names>PB</given-names></name><etal/></person-group><article-title>A model of internalized stigma and its effects on people with mental illness</article-title><source>Psychiat Serv</source><year>2013</year><volume>64</volume><fpage>264</fpage><lpage>269</lpage></element-citation></ref><ref id="b6-ndt-14-383"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname><given-names>PW</given-names></name><name><surname>Larson</surname><given-names>JE</given-names></name><name><surname>R&#x000fc;sch</surname><given-names>N</given-names></name></person-group><article-title>Self-stigma and the &#x0201c;why try&#x0201d; effect: Impact on life goals and evidence-based practices</article-title><source>World Psychiatry</source><year>2009</year><volume>8</volume><issue>2</issue><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">19516923</pub-id></element-citation></ref><ref id="b7-ndt-14-383"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ociskova</surname><given-names>M</given-names></name><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Kamaradova</surname><given-names>D</given-names></name><name><surname>Grambal</surname><given-names>A</given-names></name><name><surname>Sigmundova</surname><given-names>Z</given-names></name></person-group><article-title>Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities</article-title><source>Neuropsychiatr Dis Treat</source><year>2015</year><volume>11</volume><fpage>1767</fpage><lpage>1779</lpage><pub-id pub-id-type="pmid">26229471</pub-id></element-citation></ref><ref id="b8-ndt-14-383"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanos</surname><given-names>PT</given-names></name><name><surname>West</surname><given-names>ML</given-names></name><name><surname>Gonzales</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Roe</surname><given-names>D</given-names></name><name><surname>Lysaker</surname><given-names>PH</given-names></name></person-group><article-title>Change in internalized stigma and social functioning among persons diagnosed with severe mental illness</article-title><source>Psychiatry Res</source><year>2012</year><volume>200</volume><issue>2&#x02013;3</issue><fpage>1032</fpage><lpage>1034</lpage><pub-id pub-id-type="pmid">22763091</pub-id></element-citation></ref><ref id="b9-ndt-14-383"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ociskova</surname><given-names>M</given-names></name><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Latalova</surname><given-names>K</given-names></name><name><surname>Kamaradova</surname><given-names>D</given-names></name><name><surname>Grambal</surname><given-names>A</given-names></name></person-group><article-title>Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients</article-title><source>Neuropsychiatr Dis Treat</source><year>2016</year><volume>12</volume><fpage>1539</fpage><lpage>1551</lpage><pub-id pub-id-type="pmid">27445474</pub-id></element-citation></ref><ref id="b10-ndt-14-383"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Grambal</surname><given-names>A</given-names></name><name><surname>Kasalova</surname><given-names>P</given-names></name><etal/></person-group><article-title>Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders</article-title><source>Neuropsychiatr Dis Treat</source><year>2016</year><volume>12</volume><fpage>2659</fpage><lpage>2676</lpage><pub-id pub-id-type="pmid">27799774</pub-id></element-citation></ref><ref id="b11-ndt-14-383"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Ociskova</surname><given-names>M</given-names></name><name><surname>Grambal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder</article-title><source>Neuropsychiatr Dis Treat</source><year>2016</year><volume>12</volume><fpage>2539</fpage><lpage>2552</lpage><pub-id pub-id-type="pmid">27785031</pub-id></element-citation></ref><ref id="b12-ndt-14-383"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>L</given-names></name><name><surname>Byrne</surname><given-names>R</given-names></name><name><surname>Morrison</surname><given-names>AP</given-names></name></person-group><article-title>An integrative cognitive model of internalized stigma in psychosis</article-title><source>Behav Cogn Psychother</source><year>2017</year><volume>45</volume><issue>6</issue><fpage>545</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">28488561</pub-id></element-citation></ref><ref id="b13-ndt-14-383"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirey</surname><given-names>JA</given-names></name><name><surname>Bruce</surname><given-names>ML</given-names></name><name><surname>Alexopoulos</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression</article-title><source>Am J Psychiatry</source><year>2001</year><volume>158</volume><issue>3</issue><fpage>479</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">11229992</pub-id></element-citation></ref><ref id="b14-ndt-14-383"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavelti</surname><given-names>M</given-names></name><name><surname>Kvrgic</surname><given-names>S</given-names></name><name><surname>Beck</surname><given-names>EM</given-names></name><name><surname>R&#x000fc;sch</surname><given-names>N</given-names></name><name><surname>Vauth</surname><given-names>R</given-names></name></person-group><article-title>Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders</article-title><source>Compr Psychiatry</source><year>2012</year><volume>53</volume><issue>5</issue><fpage>468</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">21956043</pub-id></element-citation></ref><ref id="b15-ndt-14-383"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamaradova</surname><given-names>D</given-names></name><name><surname>Latalova</surname><given-names>K</given-names></name><name><surname>Prasko</surname><given-names>J</given-names></name><etal/></person-group><article-title>Connection between self-stigma, adherence to treatment, and discontinuation of medication</article-title><source>Patient Prefer Adherence</source><year>2016</year><volume>10</volume><fpage>1289</fpage><lpage>1298</lpage><pub-id pub-id-type="pmid">27524884</pub-id></element-citation></ref><ref id="b16-ndt-14-383"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinculova</surname><given-names>A</given-names></name><name><surname>Kamaradova</surname><given-names>D</given-names></name><name><surname>Ociskova</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adherence, self-stigma, and discontinuation of pharmacotherapy in anxiety disorders &#x02013; Cross-sectional study</article-title><source>Eur Psychiatry</source><year>2015</year><volume>30</volume><issue>Suppl. 1</issue><fpage>1113</fpage></element-citation></ref><ref id="b17-ndt-14-383"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>KM</given-names></name><name><surname>Tsang</surname><given-names>HW</given-names></name><name><surname>Corrigan</surname><given-names>PW</given-names></name></person-group><article-title>Self-stigma of people with schizophrenia as predictor of their adherence to psychosocial treatment</article-title><source>Psychiatr Rehabil J</source><year>2008</year><volume>32</volume><issue>2</issue><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">18840563</pub-id></element-citation></ref><ref id="b18-ndt-14-383"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandelow</surname><given-names>B</given-names></name><name><surname>Michaelis</surname><given-names>S</given-names></name></person-group><article-title>Epidemiology of anxiety disorders in the 21st century</article-title><source>Dialogues Clin Neurosci</source><year>2015</year><volume>17</volume><issue>3</issue><fpage>327</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">26487813</pub-id></element-citation></ref><ref id="b19-ndt-14-383"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000e9;pine</surname><given-names>JP</given-names></name></person-group><article-title>Epidemiology, burden, and disability in depression and anxiety</article-title><source>J Clin Psychiatry</source><year>2001</year><volume>62</volume><issue>Suppl 13</issue><fpage>4</fpage><lpage>10</lpage></element-citation></ref><ref id="b20-ndt-14-383"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bystritsky</surname><given-names>A</given-names></name></person-group><article-title>Treatment-resistant anxiety disorders</article-title><source>Molec Psychiatry</source><year>2006</year><volume>11</volume><issue>9</issue><fpage>805</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">16847460</pub-id></element-citation></ref><ref id="b21-ndt-14-383"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>D</given-names></name><name><surname>Woods</surname><given-names>R</given-names></name><name><surname>Lawson</surname><given-names>R</given-names></name><name><surname>Taylor</surname><given-names>D</given-names></name></person-group><article-title>Efficacy of drug treatments for generalized anxiety disorder: systematic review and meta-analysis</article-title><source>BMJ</source><year>2011</year><volume>342</volume><fpage>d1199</fpage><pub-id pub-id-type="pmid">21398351</pub-id></element-citation></ref><ref id="b22-ndt-14-383"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Ameringen</surname><given-names>M</given-names></name><name><surname>Mancini</surname><given-names>C</given-names></name><name><surname>Pipe</surname><given-names>B</given-names></name><name><surname>Greist</surname><given-names>JH</given-names></name><name><surname>Hollander</surname><given-names>E</given-names></name><name><surname>Montgomery</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Optimizing treatment in social phobia: A review of treatment resistance</article-title><source>CNS Spectr</source><year>2004</year><volume>9</volume><issue>10</issue><fpage>753</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">15448580</pub-id></element-citation></ref><ref id="b23-ndt-14-383"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>RL</given-names></name><name><surname>Lydiard</surname><given-names>RB</given-names></name></person-group><article-title>Management of treatment-resistant panic disorder</article-title><source>Psychiatry (Edgemont)</source><year>2007</year><volume>4</volume><issue>10</issue><fpage>48</fpage><lpage>59</lpage></element-citation></ref><ref id="b24-ndt-14-383"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Kamaradova</surname><given-names>D</given-names></name><name><surname>Cakirpaloglu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Predicting the therapeutic response to intensive psychotherapeutic programs in patients with neurotic spectrum disorders</article-title><source>Activitas Nervosa Super Rediviva</source><year>2015</year><volume>57</volume><issue>1&#x02013;2</issue><fpage>30</fpage><lpage>39</lpage></element-citation></ref><ref id="b25-ndt-14-383"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofman</surname><given-names>SG</given-names></name></person-group><article-title>Cognitive factors that maintain social anxiety disorder: A comprehensive model and its treatment implications</article-title><source>Cogn Behav Ther</source><year>2007</year><volume>36</volume><issue>4</issue><fpage>193</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">18049945</pub-id></element-citation></ref><ref id="b26-ndt-14-383"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>QJJ</given-names></name><name><surname>Rapee</surname><given-names>RM</given-names></name></person-group><article-title>The aetiology and maintenance of social anxiety disorder: A synthesis of complimentary theoretical models and formulation of a new integrated model</article-title><source>J Affect Disord</source><year>2016</year><volume>203</volume><fpage>84</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">27280967</pub-id></element-citation></ref><ref id="b27-ndt-14-383"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hettema</surname><given-names>JM</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name></person-group><article-title>A review and meta-analysis of the genetic epidemiology of anxiety disorders</article-title><source>Am J Psychiatry</source><year>2001</year><volume>158</volume><issue>10</issue><fpage>1568</fpage><lpage>1578</lpage><pub-id pub-id-type="pmid">11578982</pub-id></element-citation></ref><ref id="b28-ndt-14-383"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lysaker</surname><given-names>PH</given-names></name><name><surname>Roe</surname><given-names>D</given-names></name><name><surname>Yanos</surname><given-names>PT</given-names></name></person-group><article-title>Toward understanding the insight paradox: Internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders</article-title><source>Schizophr Bull</source><year>2007</year><volume>33</volume><issue>1</issue><fpage>192</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">16894025</pub-id></element-citation></ref><ref id="b29-ndt-14-383"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>J</given-names></name><name><surname>Buron</surname><given-names>A</given-names></name><name><surname>Bruffaerts</surname><given-names>R</given-names></name><etal/></person-group><article-title>Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys</article-title><source>Acta Psychiatr Scand</source><year>2008</year><volume>118</volume><issue>4</issue><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">18754833</pub-id></element-citation></ref><ref id="b30-ndt-14-383"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lysaker</surname><given-names>PH</given-names></name><name><surname>Yanos</surname><given-names>P</given-names></name><name><surname>Outcalt</surname><given-names>J</given-names></name><name><surname>Roe</surname><given-names>D</given-names></name></person-group><article-title>Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia</article-title><source>Clin Schizophr Relat Psychoses</source><year>2010</year><volume>4</volume><issue>1</issue><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">20643628</pub-id></element-citation></ref><ref id="b31-ndt-14-383"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Link</surname><given-names>BG</given-names></name><name><surname>Struening</surname><given-names>EL</given-names></name><name><surname>Rahav</surname><given-names>M</given-names></name><name><surname>Phelan</surname><given-names>JC</given-names></name><name><surname>Nuttbrock</surname><given-names>L</given-names></name></person-group><article-title>On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse</article-title><source>J Health Soc Behav</source><year>1997</year><volume>38</volume><fpage>177</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">9212538</pub-id></element-citation></ref><ref id="b32-ndt-14-383"><label>32</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>International Classification of Disorders</collab></person-group><source>Mental and behavioural disorders: Research diagnostic criteria</source><comment>10th revision (Czech translation)</comment><publisher-loc>Prague</publisher-loc><publisher-name>Prague Psychiatric Centre</publisher-name><year>1996</year></element-citation></ref><ref id="b33-ndt-14-383"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Lecrubier</surname><given-names>Y</given-names></name><name><surname>Sheehan</surname><given-names>KH</given-names></name><etal/></person-group><article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title><source>J Clin Psychiatry</source><year>1998</year><volume>59</volume><issue>Suppl 20</issue><fpage>22</fpage><lpage>33</lpage></element-citation></ref><ref id="b34-ndt-14-383"><label>34</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>W</given-names></name></person-group><source>ECDEU Assessment manual for psychopharmacology</source><publisher-loc>Rockville</publisher-loc><publisher-name>DHEW</publisher-name><year>1976</year></element-citation></ref><ref id="b35-ndt-14-383"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadouri</surname><given-names>A</given-names></name><name><surname>Corruble</surname><given-names>E</given-names></name><name><surname>Falissard</surname><given-names>B</given-names></name></person-group><article-title>The improved Clinical Global Impression Scale (iCGI): Development and validation in depression</article-title><source>BMC Psychiatry</source><year>2007</year><volume>7</volume><fpage>7</fpage><pub-id pub-id-type="pmid">17284321</pub-id></element-citation></ref><ref id="b36-ndt-14-383"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Epstein</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>G</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name></person-group><article-title>An inventory for measuring clinical anxiety: Psychometric properties</article-title><source>J Consult Clin Psychology</source><year>1988</year><volume>56</volume><fpage>893</fpage><lpage>897</lpage></element-citation></ref><ref id="b37-ndt-14-383"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ayala</surname><given-names>RJ</given-names></name><name><surname>Vonderharr-Carlson</surname><given-names>DJ</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name></person-group><article-title>Assessing the reliability of the Beck Anxiety Inventory scores</article-title><source>Educ Psychol Meas</source><year>2005</year><volume>65</volume><issue>5</issue><fpage>742</fpage><lpage>756</lpage></element-citation></ref><ref id="b38-ndt-14-383"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamaradova</surname><given-names>D</given-names></name><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Latalova</surname><given-names>K</given-names></name><etal/></person-group><article-title>Psychometric properties of the Czech version of the Beck Anxiety Inventory &#x02013; Comparison between diagnostic groups</article-title><source>Neuro Endocrinol Lett</source><year>2015</year><volume>36</volume><issue>7</issue><fpage>706</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">26859595</pub-id></element-citation></ref><ref id="b39-ndt-14-383"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name><name><surname>Ball</surname><given-names>R</given-names></name><name><surname>Ranieri</surname><given-names>W</given-names></name></person-group><article-title>Comparison of Beck Depression Inventories-IA and II in psychiatric outpatients</article-title><source>J Pers Assess</source><year>1996</year><volume>67</volume><fpage>588</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">8991972</pub-id></element-citation></ref><ref id="b40-ndt-14-383"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storch</surname><given-names>EA</given-names></name><name><surname>Roberti</surname><given-names>JW</given-names></name><name><surname>Roth</surname><given-names>DA</given-names></name></person-group><article-title>Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory &#x02013; Second Edition in a sample of college students</article-title><source>Depress Anxiety</source><year>2004</year><volume>19</volume><issue>3</issue><fpage>187</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">15129421</pub-id></element-citation></ref><ref id="b41-ndt-14-383"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ociskova</surname><given-names>M</given-names></name><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Kupka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Psychometric evaluation of the Czech Beck Depression Inventory&#x02013;II in a sample of depressed patients and healthy controls</article-title><source>Neuro Endocrinol Lett</source><year>2017</year><volume>38</volume><issue>2</issue><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">28650603</pub-id></element-citation></ref><ref id="b42-ndt-14-383"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritsher</surname><given-names>JB</given-names></name><name><surname>Otilingam</surname><given-names>PG</given-names></name><name><surname>Grajales</surname><given-names>M</given-names></name></person-group><article-title>Internalized stigma of mental illness: Psychometric properties of a new measure</article-title><source>Psychiatry Res</source><year>2003</year><volume>121</volume><issue>1</issue><fpage>31</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">14572622</pub-id></element-citation></ref><ref id="b43-ndt-14-383"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ociskova</surname><given-names>M</given-names></name><name><surname>Prasko</surname><given-names>J</given-names></name><name><surname>Kamar&#x000e1;dov&#x000e1;</surname><given-names>D&#x02019;</given-names></name><etal/></person-group><article-title>Self-stigma in psychiatric patients &#x02013; Standardization of the ISMI scale</article-title><source>Neuro Endocrinol Lett</source><year>2014</year><volume>35</volume><issue>7</issue><fpage>624</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">25617887</pub-id></element-citation></ref><ref id="b44-ndt-14-383"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>EM</given-names></name><name><surname>Putnam</surname><given-names>FW</given-names></name></person-group><article-title>Development, reliability, and validity of a dissociation scale</article-title><source>J Nerv Ment Dis</source><year>1986</year><volume>174</volume><issue>12</issue><fpage>727</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">3783140</pub-id></element-citation></ref><ref id="b45-ndt-14-383"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>DA</given-names></name><name><surname>Gullion</surname><given-names>CM</given-names></name><name><surname>Petty</surname><given-names>F</given-names></name><name><surname>Hardy</surname><given-names>BW</given-names></name><name><surname>Murdock</surname><given-names>MV</given-names></name><name><surname>Rush</surname><given-names>AJ</given-names></name></person-group><article-title>Tridimensional Personality Questionnaire and serotonin in bulimia nervosa</article-title><source>Psychiatry Res</source><year>1993</year><volume>48</volume><issue>1</issue><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">8416020</pub-id></element-citation></ref><ref id="b46-ndt-14-383"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ptacek</surname><given-names>R</given-names></name><name><surname>Bob</surname><given-names>P</given-names></name><name><surname>Paclt</surname><given-names>I</given-names></name></person-group><article-title>Skala disociativnich zkusenosti &#x02013; ceska verze [Dissociative Experiences Scale &#x02013; A Czech version]</article-title><source>Ceskoslovenska psycholologie</source><year>2006</year><volume>50</volume><issue>3</issue><fpage>262</fpage><lpage>272</lpage><comment>Czech with an English abstract</comment></element-citation></ref><ref id="b47-ndt-14-383"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>DV</given-names></name><name><surname>Harnett-Sheehan</surname><given-names>K</given-names></name><name><surname>Raj</surname><given-names>BA</given-names></name></person-group><article-title>The measurement of disability</article-title><source>Int Clin Psychopharmacol</source><year>1996</year><volume>11</volume><issue>Suppl 3</issue><fpage>89</fpage><lpage>95</lpage></element-citation></ref><ref id="b48-ndt-14-383"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon</surname><given-names>AC</given-names></name><name><surname>Shear</surname><given-names>MK</given-names></name><name><surname>Portera</surname><given-names>L</given-names></name><name><surname>Klerman</surname><given-names>GL</given-names></name></person-group><article-title>Assessing impairment in patients with panic disorder: the Sheehan Disability Scale</article-title><source>Soc Psychiatry Psychiatr Epidemiol</source><year>1992</year><volume>27</volume><issue>2</issue><fpage>78</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">1594977</pub-id></element-citation></ref><ref id="b49-ndt-14-383"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>KH</given-names></name><name><surname>Sheehan</surname><given-names>DV</given-names></name></person-group><article-title>Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale</article-title><source>Int Clin Psychopharmacol</source><year>2008</year><volume>23</volume><issue>2</issue><fpage>70</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">18301121</pub-id></element-citation></ref><ref id="b50-ndt-14-383"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbuckle</surname><given-names>R</given-names></name><name><surname>Frye</surname><given-names>MA</given-names></name><name><surname>Brecher</surname><given-names>M</given-names></name><etal/></person-group><article-title>The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder</article-title><source>Psychiatry Res</source><year>2009</year><volume>165</volume><issue>1&#x02013;2</issue><fpage>163</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">19042030</pub-id></element-citation></ref><ref id="b51-ndt-14-383"><label>51</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><source>Statistical power analysis for the behavioral sciences (second edition)</source><publisher-loc>Hillsdale</publisher-loc><publisher-name>Lawrence Erlbaum Associates</publisher-name><year>1988</year></element-citation></ref><ref id="b52-ndt-14-383"><label>52</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>EMEA</collab></person-group><source>Guideline for good clinical practice</source><publisher-loc>London</publisher-loc><publisher-name>EMEA</publisher-name><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf">http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf</ext-link></comment><date-in-citation>Accessed September 15, 2017</date-in-citation></element-citation></ref><ref id="b53-ndt-14-383"><label>53</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Finney</surname><given-names>SJ</given-names></name><name><surname>DiStefano</surname><given-names>C</given-names></name></person-group><article-title>Non-normal and categorical data in structural equation modeling</article-title><person-group person-group-type="editor"><name><surname>Hancock</surname><given-names>GR</given-names></name><name><surname>Mueller</surname><given-names>RD</given-names></name></person-group><source>Structural Equation Modeling: A Second Course</source><publisher-loc>Greenwich</publisher-loc><publisher-name>Information Age Publishing</publisher-name><year>2006</year><fpage>269</fpage><lpage>314</lpage></element-citation></ref><ref id="b54-ndt-14-383"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>J</given-names></name><name><surname>Angermeyer</surname><given-names>MC</given-names></name><name><surname>Bernert</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project</article-title><source>Acta Psychiatr Scand Suppl</source><year>2004</year><issue>420</issue><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15128384</pub-id></element-citation></ref><ref id="b55-ndt-14-383"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michael</surname><given-names>T</given-names></name><name><surname>Zetsche</surname><given-names>U</given-names></name><name><surname>Margraf</surname><given-names>J</given-names></name></person-group><article-title>Epidemiology of anxiety disorders</article-title><source>Epidemiol Psychopharmacol</source><year>2007</year><volume>6</volume><issue>4</issue><fpage>136</fpage><lpage>142</lpage></element-citation></ref><ref id="b56-ndt-14-383"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Abramowitz</surname><given-names>JS</given-names></name><name><surname>McKay</surname><given-names>D</given-names></name></person-group><article-title>Non-adherence and non-response in the treatment of anxiety disorders</article-title><source>J Anxiety Disord</source><year>2012</year><volume>26</volume><issue>5</issue><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">22440391</pub-id></element-citation></ref><ref id="b57-ndt-14-383"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname><given-names>D</given-names></name><name><surname>Hasson-Ohayon</surname><given-names>I</given-names></name><name><surname>Mashiach-Eizenberg</surname><given-names>M</given-names></name><name><surname>Derhy</surname><given-names>O</given-names></name><name><surname>Lysaker</surname><given-names>PH</given-names></name><name><surname>Yanos</surname><given-names>PT</given-names></name></person-group><article-title>Narrative Enhancement and Cognitive Therapy (NECT) effectiveness: A quasi-experimental study</article-title><source>J Clin Psychol</source><year>2014</year><volume>70</volume><issue>4</issue><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">24114797</pub-id></element-citation></ref><ref id="b58-ndt-14-383"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Open Science Collaboration</collab></person-group><article-title>Estimating the reproducibility of psychological science</article-title><source>Science</source><year>2015</year><volume>349</volume><issue>6251</issue><fpage>aac4716</fpage><pub-id pub-id-type="pmid">26315443</pub-id></element-citation></ref><ref id="b59-ndt-14-383"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname><given-names>PW</given-names></name><name><surname>Watson</surname><given-names>AC</given-names></name></person-group><article-title>Understanding the impact of stigma on people with mental illness</article-title><source>World Psychiatry</source><year>2002</year><volume>1</volume><issue>1</issue><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16946807</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ndt-14-383" position="float"><label>Figure 1</label><caption><p>Mediation model with self-stigma as a predictor and the relative change of the overall psychopathology as an outcome.</p><p><bold>Note:</bold> Numbers indicate the strength of pathways.</p><p><bold>Abbreviations:</bold> BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; DES, Dissociative Experience Scale; ISMI, The Internalized Stigma of Mental Illness Scale; relobjCGI, relative change of the objective Clinical Global Impression.</p></caption><graphic xlink:href="ndt-14-383Fig1"/></fig><table-wrap id="t1-ndt-14-383" position="float"><label>Table 1</label><caption><p>Descriptive and clinical characteristics of the sample and changes during the treatment</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Factor</th><th valign="top" align="left" rowspan="1" colspan="1">Number or mean</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of the patients</td><td valign="top" align="left" rowspan="1" colspan="1">209</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="left" rowspan="1" colspan="1">39.2&#x000b1;12.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender: male/female</td><td valign="top" align="left" rowspan="1" colspan="1">71 (34%)/138 (66%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education: primary/vocational training/secondary/tertiary</td><td valign="top" align="left" rowspan="1" colspan="1">22 (10.5%)/61 (29.2%)/93 (44.5%)/33 (15.8%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Employed: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">129 (61.7%)/80 (38.3%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pension: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">29 (13.9%)/180 (86.1%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Marital status: single/married/divorced/widowed</td><td valign="top" align="left" rowspan="1" colspan="1">88 (42.1%)/76 (36.4%)/39 (18.7%)/6 (2.9%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Partner: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">122 (58.4%)/87 (41.6%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disorder: AP/SP/PD/GAD/MADD</td><td valign="top" align="left" rowspan="1" colspan="1">13 (6.2%)/43 (20.6%)/64 (30.6%)/55 (26.3%)/34 (11.7%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Comorbid personality disorder: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">33 (15.8%)/176 (84.2%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Comorbid depression: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">16 (7.7%)/193 (92.3%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Comorbid anxiety disorder: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">52 (24.9%)/157 (75.1%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset of the disorder in years</td><td valign="top" align="left" rowspan="1" colspan="1">29.5&#x000b1;13.8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of psychiatric hospitalizations</td><td valign="top" align="left" rowspan="1" colspan="1">1.8&#x000b1;2.0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Length of the treatment in years</td><td valign="top" align="left" rowspan="1" colspan="1">9.7&#x000b1;9.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Positive familial anamnesis: Yes/No</td><td valign="top" align="left" rowspan="1" colspan="1">115 (55.0%)/94 (45.0%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Psychotherapy: CBT/short psychodynamic therapy</td><td valign="top" align="left" rowspan="1" colspan="1">89 (42.6%)/120 (57.4%)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">objCGI: At the start of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">4.4&#x000b1;1.0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;At the end of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">2.7&#x000b1;1.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Paired <italic>t</italic>-test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>t</italic>=21.767; <italic>df</italic>=204; <italic>P</italic>&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">subjCGI: At the start of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">4.4&#x000b1;1.3</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;At the end of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">3.3&#x000b1;1.3</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Paired <italic>t</italic>-test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>t</italic>=9.089; <italic>df</italic>=185; <italic>P</italic>&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BAI: At the start of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">25.0&#x000b1;11.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;At the end of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">22.2&#x000b1;14.0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Paired <italic>t</italic>-test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>t</italic>=3.248; <italic>df</italic>=202; <italic>P</italic>&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDI-II: At the start of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">26.0&#x000b1;10.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;At the end of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">21.1&#x000b1;12.8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Paired <italic>t</italic>-test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>t</italic>=6.054; <italic>df</italic>=201; <italic>P</italic>&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ISMI: At the start of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">66.6&#x000b1;12.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;At the end of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">63.1&#x000b1;13.8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Paired <italic>t</italic>-test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>t</italic>=&#x02212;2.310; <italic>df</italic>=100; <italic>P</italic>&#x0003c;0.05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DES</td><td valign="top" align="left" rowspan="1" colspan="1">15.4&#x000b1;13.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDS &#x02013; Work</td><td valign="top" align="left" rowspan="1" colspan="1">5.2&#x000b1;3.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDS &#x02013; Social Life</td><td valign="top" align="left" rowspan="1" colspan="1">6.1&#x000b1;2.6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDS &#x02013; Family Life/Home Responsibilities</td><td valign="top" align="left" rowspan="1" colspan="1">5.8&#x000b1;2.7</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ndt-14-383"><p><bold>Notes:</bold> Data are shown as mean &#x000b1; SD unless otherwise specified. <italic>P</italic>&#x0003c;0.05 was considered significant.</p></fn><fn id="tfn2-ndt-14-383"><p><bold>Abbreviations:</bold> AP, agoraphobia; SP, social phobia; PD, panic disorder; GAD, generalized anxiety disorder; MADD, mixed anxiety-depressive disorder; CBT, cognitive behavioral therapy; objCGI, objective Clinical Global Impression; subjCGI, subjective Clinical Global Impression; BDI-II, Beck Depression Inventory, the second edition; BAI, Beck Anxiety Inventory; DES, Dissociative Experience Scale; ISMI, The Internalized Stigma of Mental Illness Scale; SDS, Sheehan Disability Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ndt-14-383" position="float"><label>Table 2</label><caption><p>Spearman&#x02019;s correlation coefficients between chosen predictive factors and indicators of the therapeutic change</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Factors</th><th valign="top" align="left" rowspan="1" colspan="1">Relative objCGI</th><th valign="top" align="left" rowspan="1" colspan="1">Relative BAI</th><th valign="top" align="left" rowspan="1" colspan="1">Relative BDI-II</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.03, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.09, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset of the disorder</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.13, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.00, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.05, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of hospitalizations</td><td valign="top" align="left" rowspan="1" colspan="1">0.11, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.04, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.03, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Length of the treatment</td><td valign="top" align="left" rowspan="1" colspan="1">0.10, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.10, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.8, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">objCGI</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.02, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.11, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">subjCGI</td><td valign="top" align="left" rowspan="1" colspan="1">0.11, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.10, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.06, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BDI-II</td><td valign="top" align="left" rowspan="1" colspan="1">0.14<xref ref-type="table-fn" rid="tfn3-ndt-14-383">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.02, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.05, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BAI</td><td valign="top" align="left" rowspan="1" colspan="1">0.18<xref ref-type="table-fn" rid="tfn3-ndt-14-383">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.20<xref ref-type="table-fn" rid="tfn4-ndt-14-383">**</xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.10, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DES</td><td valign="top" align="left" rowspan="1" colspan="1">0.17<xref ref-type="table-fn" rid="tfn3-ndt-14-383">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.11, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.21<xref ref-type="table-fn" rid="tfn4-ndt-14-383">**</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ISMI &#x02013; Total score</td><td valign="top" align="left" rowspan="1" colspan="1">0.28<xref ref-type="table-fn" rid="tfn5-ndt-14-383">***</xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.09, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.11, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDS &#x02013; Work</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.03, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.01, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDS &#x02013; Social Life</td><td valign="top" align="left" rowspan="1" colspan="1">0.14, <italic>P</italic>=0.051</td><td valign="top" align="left" rowspan="1" colspan="1">0.03, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.02, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SDS &#x02013; Family Life/Home Responsibilities</td><td valign="top" align="left" rowspan="1" colspan="1">0.03, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.02, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.01, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Antidepressant index</td><td valign="top" align="left" rowspan="1" colspan="1">0.04, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.05, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.01, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Anxiolytic index</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.02, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.02, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Antipsychotic index</td><td valign="top" align="left" rowspan="1" colspan="1">0.17, ns</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.07, ns</td><td valign="top" align="left" rowspan="1" colspan="1">0.03, ns</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Notes:</bold></p></fn><fn id="tfn3-ndt-14-383"><label>*</label><p><italic>P</italic>&#x0003c;0.05;</p></fn><fn id="tfn4-ndt-14-383"><label>**</label><p><italic>P</italic>&#x0003c;0.01;</p></fn><fn id="tfn5-ndt-14-383"><label>***</label><p><italic>P</italic>&#x0003c;0.001.</p></fn><fn id="tfn6-ndt-14-383"><p><bold>Abbreviations:</bold> objCGI, objective Clinical Global Impression; subjCGI, subjective Clinical Global Impression; BDI-II, Beck Depression Inventory, the second edition; BAI, Beck Anxiety Inventory; DES, Dissociative Experience Scale; ISMI, The Internalized Stigma of Mental Illness Scale; SDS, Sheehan Disability Scale; ns, non-significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ndt-14-383" position="float"><label>Table 3</label><caption><p>Relationship between selected demographic and clinical factors and therapeutic change</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Factors</th><th valign="top" align="left" rowspan="1" colspan="1">Relative objCGI</th><th valign="top" align="left" rowspan="1" colspan="1">Relative BAI</th><th valign="top" align="left" rowspan="1" colspan="1">Relative BDI-II</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Male</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.37&#x000b1;0.28</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.14&#x000b1;0.51</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.23&#x000b1;0.63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Female</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.37&#x000b1;0.24</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.08&#x000b1;1.53</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.13&#x000b1;0.58</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,549, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =3,912, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =3,658<xref ref-type="table-fn" rid="tfn7-ndt-14-383">*</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Primary</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.33&#x000b1;0.30</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.24&#x000b1;0.09</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.07&#x000b1;0.65</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Vocational training</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.38&#x000b1;0.29</td><td valign="top" align="left" rowspan="1" colspan="1">0.18&#x000b1;1.00</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.12&#x000b1;0.56</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Secondary</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.36&#x000b1;0.23</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.08&#x000b1;0.59</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.17&#x000b1;0.58</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Tertiary</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.40&#x000b1;0.22</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.53&#x000b1;2.70</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.28&#x000b1;0.67</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Kruskal&#x02013;Wallis test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.508, ns</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=4.219, ns</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.187, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Heredity</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.38&#x000b1;0.27</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.01&#x000b1;0.74</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.14&#x000b1;0.60</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.36&#x000b1;0.24</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.21&#x000b1;1.73</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.19&#x000b1;0.59</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,927, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,798, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =5,021, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Occupation</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.40&#x000b1;0.26</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.13&#x000b1;1.55</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.20&#x000b1;0.56</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.33&#x000b1;0.24</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.04&#x000b1;0.59</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.11&#x000b1;0.64</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =3,987<xref ref-type="table-fn" rid="tfn7-ndt-14-383">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">U =4,720, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,578, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pension</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.37&#x000b1;0.25</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.05&#x000b1;0.54</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.15&#x000b1;0.46</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.37&#x000b1;0.26</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.10&#x000b1;1.36</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.17&#x000b1;0.61</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =2,510, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =2,407, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =2,361, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Marital status</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Single</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.36&#x000b1;0.25</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06&#x000b1;0.60</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.14&#x000b1;0.58</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Married</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.38&#x000b1;0.29</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06&#x000b1;0.74</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.18&#x000b1;0.56</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Divorced</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.39&#x000b1;0.22</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.41&#x000b1;2.51</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.17&#x000b1;0.73</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Widowed</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.34&#x000b1;0.21</td><td valign="top" align="left" rowspan="1" colspan="1">0.81&#x000b1;1.80</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.20&#x000b1;0.12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Kruskal&#x02013;Wallis test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.165, ns</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.058, ns</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=0.891, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Partner</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.40&#x000b1;0.25</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.19&#x000b1;1.53</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.20&#x000b1;0.63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.33&#x000b1;0.26</td><td valign="top" align="left" rowspan="1" colspan="1">0.04&#x000b1;0.76</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.12&#x000b1;0.54</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =0.4250<xref ref-type="table-fn" rid="tfn7-ndt-14-383">*</xref></td><td valign="top" align="left" rowspan="1" colspan="1">U=4673, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U=4505, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Psychotherapy</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;CBT</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.39&#x000b1;0.24</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.07&#x000b1;0.55</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.19&#x000b1;0.63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Short psychodynamic therapy</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.36&#x000b1;0.27</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.11&#x000b1;1.63</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.14&#x000b1;0.57</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,796, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,861, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =4,556, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Category of disorder</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Panic disorder + agoraphobia</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.35&#x000b1;0.23</td><td valign="top" align="left" rowspan="1" colspan="1">0.16&#x000b1;1.10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.05&#x000b1;0.70</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Social phobia</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.41&#x000b1;0.20</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.06&#x000b1;0.48</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.20&#x000b1;0.55</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;GAD + MADD</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.36&#x000b1;0.30</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.29&#x000b1;1.70</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.23&#x000b1;0.53</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Kruskal&#x02013;Wallis test</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=2.210, ns</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=0.644</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=2.121, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Comorbidity with personality disorder</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.29&#x000b1;0.28</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.12&#x000b1;0.77</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.07&#x000b1;0.61</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.38&#x000b1;0.25</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.13&#x000b1;1.35</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.18&#x000b1;0.59</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =2,151, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =2,320, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =2,302, ns</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Comorbidity with anxiety disorder</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.33&#x000b1;0.25</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.05&#x000b1;0.76</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.09&#x000b1;0.60</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.38&#x000b1;0.26</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.11&#x000b1;1.41</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.19&#x000b1;0.59</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Mann&#x02013;Whitney U</td><td valign="top" align="left" rowspan="1" colspan="1">U =3,327, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =3,747, ns</td><td valign="top" align="left" rowspan="1" colspan="1">U =3,438, ns</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Notes:</bold></p></fn><fn id="tfn7-ndt-14-383"><label>*</label><p><italic>P</italic>&#x0003c;0.05. Data are presented as mean &#x000b1; SD.</p></fn><fn id="tfn8-ndt-14-383"><p><bold>Abbreviations:</bold> objCGI, objective Clinical Global Impression; BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory, the second edition; GAD, generalized anxiety disorder; MADD, mixed anxiety-depressive disorder; CBT, cognitive behavioral therapy; ns, non-significant.</p></fn></table-wrap-foot></table-wrap></floats-group></article>